Company Plans Clinical Trial of Autonomic Regulation Therapy to Treat Heart Failure
geralt / Pixabay

Company Plans Clinical Trial of Autonomic Regulation Therapy to Treat Heart Failure

According to a story from Compelo, the medical technology company LivaNova is kicking off an international trial that will assess the use of autonomic regulation therapy as a treatment for…

Continue Reading Company Plans Clinical Trial of Autonomic Regulation Therapy to Treat Heart Failure
Risk of Heart Failure in Older Women Can be Reduced With Exercise, Study Says
Ben_Kerckx / Pixabay

Risk of Heart Failure in Older Women Can be Reduced With Exercise, Study Says

According to a story from Reuters, a recent study found that mild exercise, such as walking, can significantly reduce the risk of heart failure in older, postmenopausal women. This large…

Continue Reading Risk of Heart Failure in Older Women Can be Reduced With Exercise, Study Says
All New Nanotechnology Disease Detection System to be Tested on Nonalcoholic Steatohepatitis
jlenhard / Pixabay

All New Nanotechnology Disease Detection System to be Tested on Nonalcoholic Steatohepatitis

According to a story from Xcomony, the tech startup Glympse Bio has been developing a sensor technology that it claims will allow doctors to detect a variety of diseases earlier…

Continue Reading All New Nanotechnology Disease Detection System to be Tested on Nonalcoholic Steatohepatitis
Patient Registry Demonstrates The Effectiveness of Translarna in Duchenne Muscular Dystrophy
suc / Pixabay

Patient Registry Demonstrates The Effectiveness of Translarna in Duchenne Muscular Dystrophy

According to a story from prnewswire.co.uk, the biopharmaceutical company PTC Therapeutics recently announced the release of initial data from the first drug registry for its product Translarna (ataluren). This registry…

Continue Reading Patient Registry Demonstrates The Effectiveness of Translarna in Duchenne Muscular Dystrophy
A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?
harshahars / Pixabay

A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?

According to a story from Boston Health News, The US Food and Drug Administration's Accelerated Approval program is being used to approve a steadily growing number of drugs in recent…

Continue Reading A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?
Rare Disease and Personal Identity: Why This Hemophilia Patient Isn’t Interested in a Cure
SoFuego / Pixabay

Rare Disease and Personal Identity: Why This Hemophilia Patient Isn’t Interested in a Cure

According to a story from The Atlantic, the continual development of gene editing technologies like CRISPR have the potential to cure a substantial portion of rare diseases that are linked…

Continue Reading Rare Disease and Personal Identity: Why This Hemophilia Patient Isn’t Interested in a Cure
She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research
FotoshopTofs / Pixabay

She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research

According to a story from 9news.com.au, the first sign that Jemima Leydon had ovarian cancer was a stomachache. Her mother Megan assumed that it was just a stomach bug that…

Continue Reading She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research
Study Highlights The Need For Precision in CAR-T Cell Therapies
allinonemovie / Pixabay

Study Highlights The Need For Precision in CAR-T Cell Therapies

According to a story from MedCity News, a recent study revealed a potential weakness of CAR-T cell immunotherapies that reveals the need for precision and caution in the extraction process.…

Continue Reading Study Highlights The Need For Precision in CAR-T Cell Therapies
Despite Effectiveness, Accelerated Approval For Acute Hepatic Porphyria Drug in Doubt
Arcaion / Pixabay

Despite Effectiveness, Accelerated Approval For Acute Hepatic Porphyria Drug in Doubt

According to a story from wtvbam.com, the drug development company Alnylam Pharmaceuticals has recently stated that it is looking less likely that its gene silencing therapy givosiran will be getting…

Continue Reading Despite Effectiveness, Accelerated Approval For Acute Hepatic Porphyria Drug in Doubt
Researchers Discover Genetic Mutation Linked to Rare Diseases in French-Canadians
FrankWinkler / Pixabay

Researchers Discover Genetic Mutation Linked to Rare Diseases in French-Canadians

According to a story from McGill University, a group of Canadian researchers have discovered a mutation in the French-Canadian population that is linked to diseases including multiple system atrophy, Parkinson's…

Continue Reading Researchers Discover Genetic Mutation Linked to Rare Diseases in French-Canadians
Clinical Trial Results Look Promising For Experimental Niemann-Pick Disease Type C Treatment
DarkoStojanovic / Pixabay

Clinical Trial Results Look Promising For Experimental Niemann-Pick Disease Type C Treatment

According to a story from BioSpace, the biopharmaceutical company Orphazyme recently announced the results from its Phase 2/3 clinical trial of its investigational drug arimoclomol. This therapy is in development…

Continue Reading Clinical Trial Results Look Promising For Experimental Niemann-Pick Disease Type C Treatment
Clinical Trial Suggests Soliris Could be an Effective Treatment for Neuromyelitis Optica Spectrum Disorders
qimono / Pixabay

Clinical Trial Suggests Soliris Could be an Effective Treatment for Neuromyelitis Optica Spectrum Disorders

According to a story from BusinessWire, the drug developer Alexion Pharmaceuticals, Inc., recently announced positive results for its Phase 3 trial testing Soliris as a therapy for neuromyelitis optica spectrum…

Continue Reading Clinical Trial Suggests Soliris Could be an Effective Treatment for Neuromyelitis Optica Spectrum Disorders
Recent Study Recommends Steering Away From Animal Models For Parkinson’s Disease Research
Kapa65 / Pixabay

Recent Study Recommends Steering Away From Animal Models For Parkinson’s Disease Research

According to a story from Parkinson's News Today, a recent analysis of Parkinson's disease research showed that scientists would benefit from relying less on animal models and instead should focus…

Continue Reading Recent Study Recommends Steering Away From Animal Models For Parkinson’s Disease Research